Cormorant Asset Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Cormorant Asset Management’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-643,825	Closed	-$3.73M	–	80
2023 Q1	$3.73M	Hold	643,825	–	–	0.25%	52
2022 Q4	$5.11M	Hold	643,825	–	–	0.34%	56
2022 Q3	$2.03M	Sell	643,825 -7,568	-1%	-$47.3K	0.14%	61
2022 Q2	$3.73M	Buy	651,393 +225,000	+53%	+$1.76M	0.28%	57
2022 Q1	$3M	Hold	426,393	–	–	0.23%	57
2021 Q4	$9.76M	Hold	426,393	–	–	0.58%	45
2021 Q3	$12.2M	Buy	+426,393	New	+$14.5M	0.5%	48

Other funds holding ICVX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

QUSVM

Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cormorant Asset Management's ICVX Position: Q2 2023 in Review

Cormorant Asset Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q2 2023, closing a stake of 643,825 shares — an estimated $3.73M sold.

Cormorant Asset Management first reported a position in ICVX in Q3 2021 and held it in 7 quarters. The position peaked at $12.2M in Q3 2021. 62 funds tracked by Wall St. Rank hold ICVX as of Q2 2023.

Cormorant Asset Management reported no remaining Icosavax, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Cormorant Asset Management sold 643,825 Icosavax, Inc. Common Stock shares in Q2 2023, an estimated $3.73M.
Cormorant Asset Management first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Cormorant Asset Management's Icosavax, Inc. Common Stock position peaked at $12.2M in Q3 2021.
62 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q2 2023.

Based on Cormorant Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.